Index Charts See Further Weakening NYSE cumulative breadth deteriorates.
May 12, 2021 | 10:25 AM EDT
All the major equity indices closed lower Tuesday with negative internals on the NYSE while the Nasdaq had negative breadth but positive up/down volume.
The charts saw violations of uptrends with some bearish stochastic crossovers added into the mix. However, in our view, the Nasdaq 100 and Nasdaq Composite suffered less damage with some large-cap growth names closing higher on the day. Whether this proves to be a potential rotation out of what we see as extended recovery names back into growth has yet to be clarified. Cumulative market breadth deteriorated as well.
The solar energy boom is the modern equivalent of the California Gold Rush of 1848.
Data from Wood Mackenzie Power & Renewables and the Solar Energy Industries Association notes that it took 40 years to reach 1 million solar installations in the U.S., but just three more years to hit 2 million installations. And the forecast for 2021 alone is 3 million installations.
Green energy exchange-traded funds (ETFs) are on the rise as earnings improve and investors pile into solar stocks. This is evidenced in the bellwether Invesco Solar ETF (TAN), which has more than doubled over the past year, though lately, it has cooled off.
Big Pharma says vaccine patent waiver sets dangerous precedent
12
published : 7 May 2021 at 08:45
12 With soaring Covid-19 rates in poorer countries like India, pressure is on for Big Pharma to waive vaccine patent protections.
NEW YORK: Waiving patent protections for Covid-19 vaccines is fiercely opposed by Big Pharma because they say it would set a precedent that could threaten future innovations, and insist the move would not speed up production.
Here are some of the consequences waiving the patent protection on novel coronavirus vaccines could have.
No immediate impact
The vaccine makers say patents are not the key factor impeding faster production.
Friday, 07 May 2021 09:41 AM MYT
Waiving patent protections for Covid-19 vaccines is fiercely opposed by Big Pharma because they say it would set a precedent that could threaten future innovations. Reuters pic
Subscribe to our Telegram channel for the latest updates on news you need to know.
NEW YORK, May 7 Waiving patent protections for Covid-19 vaccines is fiercely opposed by Big Pharma because they say it would set a precedent that could threaten future innovations, and insist the move would not speed up production.
Here are some of the consequences waiving the patent protection on novel coronavirus vaccines could have.
No immediate impact